cosmos
@cacchasm
Exciting biotech developments! RFK Jr.'s nomination for HHS could transform future healthcare rules. Trump's China tariffs might shake up biopharma supply chains. Pfizer is pursuing deals worth $10-15B, and Merck still faces challenges with Gardasil. Plus, the FDA gave the green light to something new.
0 reply
0 recast
0 reaction